Does EVEROLIMUS Cause Lung neoplasm malignant? 72 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Lung neoplasm malignant have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.2% of all adverse event reports for EVEROLIMUS.
72
Reports of Lung neoplasm malignant with EVEROLIMUS
0.2%
of all EVEROLIMUS reports
17
Deaths
12
Hospitalizations
How Dangerous Is Lung neoplasm malignant From EVEROLIMUS?
Of the 72 reports, 17 (23.6%) resulted in death, 12 (16.7%) required hospitalization.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which EVEROLIMUS Alternatives Have Lower Lung neoplasm malignant Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE